drugset / Trial / NCT03641950
The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is evaluate the efficacy and safety of Botulax® in the treatment of Essential blepharospasm.
Timeline
- Start
- 2015-04-30
- Primary completion
- 2015-05
- Completion
- 2016-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1.25 iu | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 2.5 iu | Intramuscular |